Financial Ratios

HESTER BIOSCIENCES LTD.

NSE : HESTERBIOBSE : 524669ISIN CODE : INE782E01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE1609.0023.95 (+1.51 %)
PREV CLOSE ( ) 1585.05
OPEN PRICE ( ) 1592.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 412
TODAY'S LOW / HIGH ( )1572.55 1624.00
52 WK LOW / HIGH ( )1292.9 1928.45
NSE1612.9527.25 (+1.72 %)
PREV CLOSE( ) 1585.70
OPEN PRICE ( ) 1585.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4167
TODAY'S LOW / HIGH( ) 1566.10 1627.85
52 WK LOW / HIGH ( )1292.85 1939.95
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)38.0246.4546.9036.7051.55
   CEPS(Rs)49.5257.6258.2347.7460.44
   DPS(Rs)8.0010.0010.006.6011.00
   Book NAV/Share(Rs)343.70315.54279.28238.72210.93
   Tax Rate(%)26.3725.8027.1724.2726.61
Margin Ratios
   Core EBITDA Margin(%)21.3727.3834.5331.1239.58
   EBIT Margin(%)19.7025.1928.1727.3136.97
   Pre Tax Margin(%)17.1624.0726.2824.3334.90
   PAT Margin (%)12.6417.8619.1418.4325.62
   Cash Profit Margin (%)16.4622.1623.7623.9730.04
Performance Ratios
   ROA(%)6.6711.1914.2712.0719.46
   ROE(%)11.5315.6218.1116.3326.94
   ROCE(%)11.9117.3123.2819.7431.15
   Asset Turnover(x)0.530.630.750.650.76
   Sales/Fixed Asset(x)1.381.321.261.031.21
   Working Capital/Sales(x)3.222.411.992.612.85
Efficiency Ratios
   Fixed Capital/Sales(x)0.720.760.790.970.83
   Receivable days99.3284.5279.0683.4168.88
   Inventory Days106.93105.37102.81117.3392.96
   Payable days90.7971.6194.44135.1899.34
Valuation Parameters
   PER(x)39.9958.4540.8725.2029.98
   PCE(x)30.7047.1232.9219.3825.57
   Price/Book(x)4.428.616.863.887.33
   Yield(%)0.530.370.520.710.71
   EV/Net Sales(x)5.7211.087.894.907.89
   EV/Core EBITDA(x)24.1137.2522.3414.9119.06
   EV/EBIT(x)28.7943.6028.0117.9321.33
   EV/CE(x)2.665.725.832.995.62
   M Cap / Sales5.0910.537.824.647.68
Growth Ratio
   Net Sales Growth(%)15.805.2223.05-1.0327.01
   Core EBITDA Growth(%)-7.69-11.4332.33-21.4737.66
   EBIT Growth(%)-9.52-5.1226.95-26.9137.53
   PAT Growth(%)-18.16-0.9627.79-28.8043.50
   EPS Growth(%)-18.16-0.9627.79-28.8043.50
Financial Stability Ratios
   Total Debt/Equity(x)0.560.450.070.240.21
   Current Ratio(x)1.582.224.032.122.53
   Quick Ratio(x)1.001.282.381.081.30
   Interest Cover(x)7.7622.5814.889.1917.87
   Total Debt/Mcap(x)0.130.050.010.060.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.